Tavira Therapeutics

Foundation date

9th June 2024

Sector

#Biotechnology - Therapeutics

Subsector

  • Transforming gene therapy with our advanced AAV delivery platform.

  • Unlock the future of gene therapy with Tavira’s targeted AAV gene delivery platform.

  • Enhancing the targeting capacity of recombinant AAVs for gene therapy through tailor made capsid conjugation

Upcoming events

Latest news

  • Biotalys Appoints Kamal El Mernissi as Chief Business Development Officer

    21 hours ago

  • InnoSer Announces Joint Initiative with Hasselt University/BIOMED to Support Preclinical Multiple Sclerosis Research

    Wednesday October 16th 2024

  • A brown ale or hoppy lager? Even fruit flies have a preference.

    Tuesday October 15th 2024